quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·136d
PRRelease
Neuphoria Therapeutics Inc. logo

Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria's Director Nominees

NEUP· Neuphoria Therapeutics Inc.
Health Care
Original source

Companies

  • NEUP
    Neuphoria Therapeutics Inc.
    Health Care

Related

  • SEC65d
    SEC Form 10-Q filed by Neuphoria Therapeutics Inc.
  • INSIDER92d
    SEC Form 4 filed by Director Wilson David Ian
  • INSIDER92d
    SEC Form 4 filed by Director Davies Peter Miles Winston
  • INSIDER92d
    SEC Form 4 filed by Director Fisher Alan
  • INSIDER92d
    SEC Form 4 filed by Director Ryan Jane
  • SEC115d
    Amendment: SEC Form SCHEDULE 13D/A filed by Neuphoria Therapeutics Inc.
  • SEC126d
    Neuphoria Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • SEC127d
    Neuphoria Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022